B2TR28 AF NFT

Glycogen synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibzgjc7vgr6da2pgpmxto6yu3ndxiturhtqodak3phwwa2agjqilq/metadata.json
IPFS of structure file: 
bafybeiar3wfkgkzxablbmxd4ndplc3cde2y4z27gbnycnsoslwtjgwcjci/AF-B2TR28-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x54E712e282c590D9A20961451A63f1380e0a3dD4
First NFT owner address (bech32): 
genesis12nn39c5zckgdngsfv9z35cl38q8q50w5w722p5
Current NFT ID #148052 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
148052
Accession (UniProt):
B2TR28
Name::
Glycogen synthase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Eklund 17B / Type B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2TR28 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2TR28|GLGA_CLOBB Glycogen synthase OS=Clostridium botulinum (strain Eklund 17B / Type B) OX=935198 GN=glgA PE=3 SV=1 MRVLFVASEAHPFIKSGGLGDVAGALPKELARKGVDVRVVIPKYREINNELKNKLRFNKWFNVDVGWRNQYCGILEYEYDGVIYYFVDNEYYFSRGGMYGHYDDAERFAFFDRAVLDMIKQLDWKPNVIHCNDWQTGMIPVLLKLEYMRKDMFYWDIKSVFSIHNIAFQGVFDPVILPELFGYDYEQYTNTNLKFDDGVGFMKGAINYSDMITTVSYSYAEEIKTPEFGERLDWLLREKSYMLRGILNGIDYDEFNPKNDSLINKNYDVNNINDKYENKRNLQSELGLSVNENIPMIAMVTRLTSQKGLDLLVHISERLLQNDIQLVIVGTGDKHYEDHFKWLDYKYGNKVSANIRFDNNLAHKAYAASDMFLMPSLFEPCGLGQLIALRYGSIPIVRETGGLKDTIRAYNEYTGEGNGFSFYNYNADELLHIIEYALKIYYDKNKWSNLVKNAMNSNNSWSKSADEYLNMYKELSYR